Rosa Alcobendas

434 citations
24 papers · 203 indexed · h-index 8

Rosa Alcobendas

20 papers receiving 200 citations

Peers

Rosa Alcobendas
Comparison fields: 5 of 40
  • Emergency Medicine 30
  • Applied Microbiology and Biotechnology 6
  • Hematology 29
  • Surgery 111
  • Rheumatology 34
Replace Agustín Remesal with:
Agustín Remesal Spain
Sara Murías Spain
Stanislas Ledochowski France
Josep Valverde Spain
Rajoo Thapa India
Stacey Rose United States
F J Vos Netherlands
Laura Smith United States
Hassan A. Majeed Kuwait
Dorde Jevtic United States
Rosa Alcobendas relative to Agustín Remesal Spain Agustín Remesal's profile →
Citations per field
00.5×1.5×2.5×
Agustín Remesal · 1×
Citations per year

Countries citing papers authored by Rosa Alcobendas

Since Specialization
Citations

This map shows the geographic impact of Rosa Alcobendas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Alcobendas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Alcobendas more than expected).

Fields of papers citing papers by Rosa Alcobendas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Alcobendas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Alcobendas. The network helps show where Rosa Alcobendas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rosa Alcobendas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rosa Alcobendas Line = papers co-authored together Rosa Alcobendas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20243
3 20232
4 20230
5 20225
6 20224
7 20229
8 20225
9 20221
10 20222
11 202211
12 202016
13 202028
14 202010
15 20203
16 201919
17 20191
18 20174
19 201657
20 20155

About Rosa Alcobendas

Rosa Alcobendas is a scholar working on Hematology, Speech and Hearing and Emergency Medicine, having authored 24 papers that have together received 203 indexed citations. Recurring topics across this work include Orthopedic Infections and Treatments (7 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Infectious Diseases and Tuberculosis (5 papers), Streptococcal Infections and Treatments (5 papers), Inflammasome and immune disorders (4 papers), Adolescent and Pediatric Healthcare (3 papers) and Hematological disorders and diagnostics (3 papers). The work is most often cited by research in Emergency Medicine (30 citations), Applied Microbiology and Biotechnology (6 citations) and Hematology (29 citations). Rosa Alcobendas has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Cristina Calvo, Agustín Remesal, Esmeralda Núñez Cuadros, Sara Murías, Jesús Saavedra‐Lozano, Daniel Clemente, Elisa Fernández-Cooke, Pere Soler‐Palacín, Marta Ruiz de Valbuena and Jaime de Inocencio Arocena. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026